Silver Spring, MD, United States of America

Christopher C Broder

This inventor holds 25 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Viral Antibodies. Top assignees: The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Florida Research Foundation Inc.. Active years: 1993-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher C Broder. Retrieved from https://idiyas.com/inventor/christopher-c-broder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 

% Patents Active = 88.0

 

 

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 87(Granted Patents)


Location History:

  • Rockville, MD (US) (1993 - 2012)
  • Silver Springs, MD (US) (2019)
  • Silver Spring, MD (US) (2011 - 2022)

Company Filing History:


Years Active: 1993-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Hendra Virus
Nipah Virus
HIV-1
Antibodies
Glycoproteins
Monoclonal Antibodies
Membrane Fusion
Cedar Virus
Chemokine Receptor
Fibrinolytic Agents
Oligomers
Viral Inhibition
25 patents (USPTO):Explore Patents

Title: Christopher C. Broder: Innovator in Viral Research and Antibody Development

Introduction

Christopher C. Broder, based in Silver Spring, MD, is a notable inventor with a significant portfolio, holding a total of 25 patents. His contributions primarily lie in the fields of viral research and antibody development, where his inventions aim to address infectious diseases.

Latest Patents

Among his most recent innovations are two pivotal patents. The first, titled "Antibodies against F glycoprotein of Hendra and Nipah viruses," centers on antibodies or antibody fragments that effectively bind, neutralize, and inhibit the Hendra and Nipah viruses. This invention not only provides a strategic approach to combat these viral threats but also includes pharmaceutical compositions featuring the antibodies this invention entails. Furthermore, it offers polynucleotides that encode these antibodies and fragments, alongside host cells that have been transformed with the relevant materials. The second recent patent focuses on "Immunogenic Cedar Virus compositions," which details a novel virus known as Cedar Virus and the methods for its utilization.

Career Highlights

Christopher has spent considerable time at esteemed organizations, including the Henry M. Jackson Foundation for the Advancement of Military Medicine and the United States Department of Health and Human Services. His work in these institutions has bolstered his innovative capacity and facilitated significant advancements in the field of medical science.

Collaborations

Throughout his career, Broder has collaborated with prominent colleagues such as Katharine Bossart and Yee-Peng Chan. These partnerships have further enhanced the depth and impact of his research, leading to groundbreaking developments in the field.

Conclusion

Christopher C. Broder exemplifies a dedicated innovator making strides in viral research and antibody development. With substantial patents to his name and valuable collaborations, his work continues to push the boundaries of medical science and contributes to public health advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…